Share
Our Company
Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference
Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference
Share

NEW BRUNSWICK, N.J., Oct. 25, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 26th Annual Credit Suisse Health Care Conference on Wednesday, Nov. 8, at The Phoenician in Scottsdale, AZ.  Vanessa Broadhurst, President, Cardiovascular & Metabolism, Janssen Pharmaceuticals and Scott White, President, Immunology, Janssen Pharmaceuticals will represent the Company in a session scheduled at 9:50 a.m. (Mountain Standard Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

 (PRNewsfoto/Johnson & Johnson)

 

SOURCE Johnson & Johnson

  • Press Contacts: Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M); Investor Contacts: Joseph Wolk, (732) 524-1142; Lesley Fishman, (732) 524-3922
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue